A snapshot of pediatric inpatients and outpatients with COVID-19 : a point prevalence study from Turkey
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature..
This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs. What is Known: • Children with COVID-19 mainly present with fever and cough, as in adults. • COVID-19 may specifically threaten children with underlying chronic diseases. What is New: • Children with obesity have a higher vaccination rate against COVID-19 than children without obesity. • Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:182 |
|---|---|
| Enthalten in: |
European journal of pediatrics - 182(2023), 7 vom: 04. Juli, Seite 3231-3242 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yılmaz, Dilek [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 21.07.2023 Date Revised 21.07.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00431-023-04982-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356439801 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356439801 | ||
| 003 | DE-627 | ||
| 005 | 20231226070450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00431-023-04982-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356439801 | ||
| 035 | |a (NLM)37140703 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yılmaz, Dilek |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A snapshot of pediatric inpatients and outpatients with COVID-19 |b a point prevalence study from Turkey |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.07.2023 | ||
| 500 | |a Date Revised 21.07.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a This multi-center point prevalence study evaluated children who were diagnosed as having coronavirus disease 2019 (COVID-19). On February 2nd, 2022, inpatients and outpatients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were included in the study from 12 cities and 24 centers in Turkey. Of 8605 patients on February 2nd, 2022, in participating centers, 706 (8.2%) had COVID-19. The median age of the 706 patients was 92.50 months, 53.4% were female, and 76.7% were inpatients. The three most common symptoms of the patients with COVID-19 were fever (56.6%), cough (41.3%), and fatigue (27.5%). The three most common underlying chronic diseases (UCDs) were asthma (3.4%), neurologic disorders (3.3%), and obesity (2.6%). The SARS-CoV-2-related pneumoniae rate was 10.7%. The COVID-19 vaccination rate was 12.5% in all patients. Among patients aged over 12 years with access to the vaccine given by the Republic of Turkey Ministry of Health, the vaccination rate was 38.7%. Patients with UCDs presented with dyspnea and pneumoniae more frequently than those without UCDs (p < 0.001 for both). The rates of fever, diarrhea, and pneumoniae were higher in patients without COVID-19 vaccinations (p = 0.001, p = 0.012, and p = 0.027). Conclusion: To lessen the effects of the disease, all eligible children should receive the COVID-19 vaccine. The illness may specifically endanger children with UCDs. What is Known: • Children with COVID-19 mainly present with fever and cough, as in adults. • COVID-19 may specifically threaten children with underlying chronic diseases. What is New: • Children with obesity have a higher vaccination rate against COVID-19 than children without obesity. • Among unvaccinated children, fever and pneumoniae might be seen at a higher ratio than among vaccinated children | ||
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Children | |
| 650 | 4 | |a Clinical presentation | |
| 650 | 4 | |a Multi-center study | |
| 650 | 4 | |a Point prevalence study | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Üstündağ, Gülnihan |e verfasserin |4 aut | |
| 700 | 1 | |a Büyükçam, Ayşe |e verfasserin |4 aut | |
| 700 | 1 | |a Salı, Enes |e verfasserin |4 aut | |
| 700 | 1 | |a Çelik, Ümit |e verfasserin |4 aut | |
| 700 | 1 | |a Avcu, Gülhadiye |e verfasserin |4 aut | |
| 700 | 1 | |a Belet, Nurşen |e verfasserin |4 aut | |
| 700 | 1 | |a Çakmak Taşkın, Esra |e verfasserin |4 aut | |
| 700 | 1 | |a Öcal Demir, Sevliya |e verfasserin |4 aut | |
| 700 | 1 | |a Birbilen, Ahmet Ziya |e verfasserin |4 aut | |
| 700 | 1 | |a Kılıç, Ömer |e verfasserin |4 aut | |
| 700 | 1 | |a Metin Akcan, Özge |e verfasserin |4 aut | |
| 700 | 1 | |a Tekin Yılmaz, Ayşe |e verfasserin |4 aut | |
| 700 | 1 | |a Aldemir Kocabaş, Bilge |e verfasserin |4 aut | |
| 700 | 1 | |a Hatipoğlu, Nevin |e verfasserin |4 aut | |
| 700 | 1 | |a Karbuz, Adem |e verfasserin |4 aut | |
| 700 | 1 | |a Çakır, Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Sütçü, Murat |e verfasserin |4 aut | |
| 700 | 1 | |a Aygün, Fatma Deniz |e verfasserin |4 aut | |
| 700 | 1 | |a Çelik, Taylan |e verfasserin |4 aut | |
| 700 | 1 | |a Bayturan Şen, Semra |e verfasserin |4 aut | |
| 700 | 1 | |a Dalgıç, Nazan |e verfasserin |4 aut | |
| 700 | 1 | |a Ümit, Zühal |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Soner Sertan |e verfasserin |4 aut | |
| 700 | 1 | |a Karadağ Öncel, Eda |e verfasserin |4 aut | |
| 700 | 1 | |a Bolat, Ahmet |e verfasserin |4 aut | |
| 700 | 1 | |a Kılıç Çil, Merve |e verfasserin |4 aut | |
| 700 | 1 | |a Turan, Caner |e verfasserin |4 aut | |
| 700 | 1 | |a Çakıl Güzin, Ayşe |e verfasserin |4 aut | |
| 700 | 1 | |a Topal, Sevgi |e verfasserin |4 aut | |
| 700 | 1 | |a Esen Besli, Gülser |e verfasserin |4 aut | |
| 700 | 1 | |a Doğan, Gizem |e verfasserin |4 aut | |
| 700 | 1 | |a Şahin, Sabiha |e verfasserin |4 aut | |
| 700 | 1 | |a Akın, Fatih |e verfasserin |4 aut | |
| 700 | 1 | |a Bildirici, Yaşar |e verfasserin |4 aut | |
| 700 | 1 | |a Timurtaş Dayar, Gülperi |e verfasserin |4 aut | |
| 700 | 1 | |a Ergül Sarı, Emine |e verfasserin |4 aut | |
| 700 | 1 | |a Kızmaz İşançlı, Didem |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Manolya |e verfasserin |4 aut | |
| 700 | 1 | |a Önal, Pınar |e verfasserin |4 aut | |
| 700 | 1 | |a Aylaç, Hakan |e verfasserin |4 aut | |
| 700 | 1 | |a Lüleci, Duygu |e verfasserin |4 aut | |
| 700 | 1 | |a Yaşar, Belma |e verfasserin |4 aut | |
| 700 | 1 | |a Dede, Elif |e verfasserin |4 aut | |
| 700 | 1 | |a Çağlar, Aykut |e verfasserin |4 aut | |
| 700 | 1 | |a Akova, Sevgi |e verfasserin |4 aut | |
| 700 | 1 | |a Afat Turgut, Elif |e verfasserin |4 aut | |
| 700 | 1 | |a Yazıcı Özkaya, Pınar |e verfasserin |4 aut | |
| 700 | 1 | |a Kandemir Gülmez, Tuğba |e verfasserin |4 aut | |
| 700 | 1 | |a Ulusoy, Emel |e verfasserin |4 aut | |
| 700 | 1 | |a Duyu, Muhterem |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Yalçın |e verfasserin |4 aut | |
| 700 | 1 | |a Çeliktaş, Hüseyin |e verfasserin |4 aut | |
| 700 | 1 | |a Tekeli, Onur |e verfasserin |4 aut | |
| 700 | 1 | |a Çağlar, Fatma |e verfasserin |4 aut | |
| 700 | 1 | |a Gül, Doruk |e verfasserin |4 aut | |
| 700 | 1 | |a Oral Cebeci, Sinem |e verfasserin |4 aut | |
| 700 | 1 | |a Battal, Fatih |e verfasserin |4 aut | |
| 700 | 1 | |a Bal, Alkan |e verfasserin |4 aut | |
| 700 | 1 | |a Aygün, Emre |e verfasserin |4 aut | |
| 700 | 1 | |a Uysalol, Metin |e verfasserin |4 aut | |
| 700 | 1 | |a Arslan, Gazi |e verfasserin |4 aut | |
| 700 | 1 | |a Özkavaklı, Ayberk |e verfasserin |4 aut | |
| 700 | 1 | |a Kızıl, Mahmut Can |e verfasserin |4 aut | |
| 700 | 1 | |a Yazar, Abdullah |e verfasserin |4 aut | |
| 700 | 1 | |a Aygün, Fatih |e verfasserin |4 aut | |
| 700 | 1 | |a Somer, Ayper |e verfasserin |4 aut | |
| 700 | 1 | |a Kuyucu, Necdet |e verfasserin |4 aut | |
| 700 | 1 | |a Dinleyici, Ener Çağrı |e verfasserin |4 aut | |
| 700 | 1 | |a Kara, Ateş |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of pediatrics |d 1978 |g 182(2023), 7 vom: 04. Juli, Seite 3231-3242 |w (DE-627)NLM000029718 |x 0340-6199 |7 nnns |
| 773 | 1 | 8 | |g volume:182 |g year:2023 |g number:7 |g day:04 |g month:07 |g pages:3231-3242 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00431-023-04982-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 182 |j 2023 |e 7 |b 04 |c 07 |h 3231-3242 | ||